BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 6791584)

  • 21. Growth media and assay plate material can impact on the effectiveness of cationic biocides and antibiotics against different bacterial species.
    Bock LJ; Hind CK; Sutton JM; Wand ME
    Lett Appl Microbiol; 2018 May; 66(5):368-377. PubMed ID: 29432643
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of Antibacterial Activity of Three Quaternary Ammonium Disinfectants on Different Germs Isolated from the Hospital Environment.
    Ramzi A; Oumokhtar B; Ez Zoubi Y; Filali Mouatassem T; Benboubker M; El Ouali Lalami A
    Biomed Res Int; 2020; 2020():6509740. PubMed ID: 33381566
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of ceftriaxone on Pseudomonas aeruginosa and Staphylococcus aureus in broth, serum, and in combination with human polymorphonuclear leukocytes.
    Bassler M; Blaschke H; Just M; Daschner FD
    Chemotherapy; 1982; 28(5):390-6. PubMed ID: 6291868
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of pH and cationic supplementation on in vitro postantibiotic effect.
    Gudmundsson A; Erlendsdottir H; Gottfredsson M; Gudmundsson S
    Antimicrob Agents Chemother; 1991 Dec; 35(12):2617-24. PubMed ID: 1810197
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Comparison of the in vitro activity of ceftazidime: in culture, in serum and in combination with granulocytes].
    Daschner FD; Bassler M; Grundau D; Dieterle L; Just HM
    Immun Infekt; 1983 Nov; 11(6):221-8. PubMed ID: 6439624
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tobramycin (nebramycin factor 6): in vitro activity against Pseudomonas aeruginosa.
    Meyer RD; Young LS; Armstrong D
    Appl Microbiol; 1971 Dec; 22(6):1147-51. PubMed ID: 5002900
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of Clinical Laboratory Standards Institute and European Committee on Antimicrobial Susceptibility Testing guidelines for the interpretation of antibiotic susceptibility at a University teaching hospital in Nairobi, Kenya: a cross-sectional study.
    Kassim A; Omuse G; Premji Z; Revathi G
    Ann Clin Microbiol Antimicrob; 2016 Apr; 15():21. PubMed ID: 27068515
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optimized protocols for assessing libraries of poorly soluble sortase A inhibitors for antibacterial activity against medically-relevant bacteria, toxicity and enzyme inhibition.
    Alharthi S; Ziora ZM; Moyle PM
    Bioorg Med Chem; 2021 Dec; 52():116527. PubMed ID: 34839159
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anomalous effect of serum on the antimicrobial activity of cefoperazone.
    Lang SD; Cameron GL; Mullins PR
    Drugs; 1981; 22 Suppl 1():52-9. PubMed ID: 6456892
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Occurrence and antibacterial susceptibility pattern of bacterial pathogens isolated from diarrheal patients in Pakistan.
    Rasool MH; Siddique AB; Saqalein M; Asghar MJ; Zahoor MA; Aslam B; Shafiq HB; Nisar MA
    Saudi Med J; 2016 Mar; 37(3):274-9. PubMed ID: 26905349
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibacterial effects of lidocaine and adrenaline.
    Kesici S; Demirci M; Kesici U
    Int Wound J; 2019 Oct; 16(5):1190-1194. PubMed ID: 31407479
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of antibiotic susceptibility test results: how guilty a laboratory could be?
    Nassar MSM; Hazzah WA; Bakr WMK
    J Egypt Public Health Assoc; 2019; 94(1):4. PubMed ID: 30686832
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro susceptibility of clinically important bacteria to amikacin: correlation of results of broth dilution and disk sensitivity tests and effect of medium composition.
    Linzenmeier G; Naumann P; Neussel H; Rosin H
    J Infect Dis; 1976 Nov; 134 SUPPL():S262-70. PubMed ID: 825584
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined effects of panipenem and aminoglycosides on methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa in vitro.
    Katou K; Nakamura A; Kato T; Tonegawa K; Kutsuna T; Niwa T; Morita H; Itoh M
    Chemotherapy; 2005 Oct; 51(6):387-91. PubMed ID: 16227698
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Establishing quality control ranges for antimicrobial susceptibility testing of Escherichia coli, Pseudomonas aeruginosa, and Staphylococcus aureus: a cornerstone to develop reference strains for Korean clinical microbiology laboratories.
    Hong SK; Choi SJ; Shin S; Lee W; Pinto N; Shin N; Lee K; Hong SG; Kim YA; Lee H; Kim H; Song W; Lee SH; Yong D; Lee K; Chong Y
    Ann Lab Med; 2015 Nov; 35(6):635-8. PubMed ID: 26354353
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Basis for nebulized antibiotics: droplet characterization and in vitro antimicrobial activity versus Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa.
    Todisco T; Eslami A; Baglioni S; Sposini T; Tascini C; Sommer E; Knoch M
    J Aerosol Med; 2000; 13(1):11-6. PubMed ID: 10947319
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cefiderocol MIC quality control ranges in iron-depleted cation-adjusted Mueller-Hinton broth using a CLSI M23-A4 multi-laboratory study design.
    Huband MD; Ito A; Tsuji M; Sader HS; Fedler KA; Flamm RK
    Diagn Microbiol Infect Dis; 2017 Jun; 88(2):198-200. PubMed ID: 28410852
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of natural curcuminoids-intercalated layered double hydroxide nanohybrid against Staphylococcus aureus, Pseudomonas aeruginosa, and Enterococcus faecalis: A bactericidal, antibiofilm, and mechanistic study.
    Gayani B; Dilhari A; Wijesinghe GK; Kumarage S; Abayaweera G; Samarakoon SR; Perera IC; Kottegoda N; Weerasekera MM
    Microbiologyopen; 2019 May; 8(5):e00723. PubMed ID: 30221843
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibacterial Activities of Clove (Syzygium aromaticum) Extracts Against Three Food Borne Pathogens: Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa.
    Mostaqim S; Saha SK; Hani U; Paul SK; Sharmin M; Basak S; Begum SA; Salma U; Shahabuddin MS
    Mymensingh Med J; 2019 Oct; 28(4):779-791. PubMed ID: 31599241
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Wide variability in Pseudomonas aeruginosa aminoglycoside results among seven susceptibility testing procedures.
    Staneck JL; Glenn S; DiPersio JR; Leist PA
    J Clin Microbiol; 1989 Oct; 27(10):2277-85. PubMed ID: 2511223
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.